Page 137 - CW E-Magazine (5-3-2024)
P. 137
Top Stories Pharmaceuticals
ADVANCED MATERIALS RAPID DIAGNOSIS
DCM Shriram announces entry into the business Bengaluru researchers develop paper-based platform
of epoxy resins to detect antibiotic-resistant bacteria
The Board of directors of DCM 2024-25. Over 80% of ECH produced products. The entire portfolio of A paper-based platform developed and JNCASR team involves incorporat- Infusing the hydrogel in a sheet of paper
Shriram Ltd., at their board meeting globally is used in the manufacture of Advanced Materials products includ- by researchers at the Indian Institute of ing biphenyl-4-carboxylic acid (BCA) as the medium reduced the cost signifi -
held in New Delhi on February 27, epoxy resins. ing liquid epoxy resins, hardeners, Science (IISc) and Jawaharlal Nehru within a supramolecular hydrogel ma- cantly. The instrument is fi tted with
accorded an in-principle approval for the solvent cuts, reactive diluents and Centre for Advanced Scientifi c Research trix containing terbium cholate (TbCh). different LEDs that shine UV radiation
entry of its Chemicals business into Commenting on the announce- formulated resins are fi nding increasing (JNCASR), Bengaluru could help quickly This hydrogel normally emits green as required. Green fl uorescence from
the domain of Advanced Materials by ment, Mr. Ajay Shriram, Chairman & applications in sectors such as wind- detect the presence of antibiotic-resis- fl uorescence when UV light is shined the enzyme is captured by a built-in
investing into epoxy resins and value- Senior Managing Director, and Mr. blades, EVs, aeronautics, electro- tant, disease-causing bacteria. on it. The next step was to fi nd a way camera, and a dedicated software app
added products. Vikram Shriram, Vice Chairman and nics, fi re-proofi ng and light-weight- to make the technology inexpensive. measures the intensity, which can help
Managing Director, DCM Shriram, ing industries and India is poised to Dr. Uday Maitra, Professor at the Currently used diagnostics instruments quantify the bacterial load.
The company is planning to invest said in a joint statement, “We are emerge as a market of choice, both for Department of Organic Chemistry, are costly, which drives up the price for
Rs. 1,000-crore over the next few years bullish about the overall prospects of domestic and global consumption, of IISc, and collaborators have developed testing. The team from IISc tied up with
to set up a greenfi eld state-of-the-art the Chemicals Business and this entry such products. DCM Shriram Ltd. will a rapid diagnosis protocol that uses a Jayanta Haldar’s research group from
epoxy manufacturing plant. It may be into the Advanced Materials space. continue to remain alert to opportu- luminescent paper-based platform to The team collaborated with a JNCASR to check their approach on
noted that the company’s epichloro- We already have some of the key raw nities arising in the adjacencies of detect the presence of antibiotic-resis- Chennai-based company, Adiuvo Diag- urine samples. As the next step, the
hydrin (ECH) plant in Jhagadia, Gujarat materials like ECH and caustic in our its core-chemicals business and look tant bacteria. nostics, to design a customised, port- researchers plan to tie up with hospitals
is in fi nal stages of completion and is portfolio, which paves a logical way to participate whole-heartedly in the able and miniature imaging device, to test this technology with samples
expected to be commissioned in Q1 of forward into the epoxy and value added India growth story.” The approach developed by the IISc named Illuminate Fluorescence Reader. from patients.
BANKING ON RESEARCH
FORM IV
(See Rule 8) Bristol Myers Squibb opens innovation hub in Hyderabad
Statement about ownership and other particulars, about newspaper CHEMICAL WEEKLY
Bristol Myers Squibb (BMS), the
1. Place of Publication MUMBAI US-based drug fi rm, opened a new inno-
2. Periodicity of its Publication WEEKLY vation hub in Hyderabad on February 26.
3. Printer’s Name R. RAGHAVAN The new facility, which can house over
Nationality Indian 1,500 employees, has been built with an
Address 144-A, Kalpataru Residency, Opp. Cine Planet, investment of more than $100-mn (nearly
Kamani Marg, Sion (East), Mumbai 400 022. Rs. 828-crore). The site will expand the
4. Publisher’s Name R. RAGHAVAN company’s global drug development
Nationality Indian
Address 144-A, Kalpataru Residency, Opp. Cine Planet, and information technology and digital
Kamani Marg, Sion (East), Mumbai 400 022. capabilities. The launch was attended by
5. Editor’s Name R. RAGHAVAN the Telangana Minister for Industries &
Nationality Indian Information Technology, Mr. D. Sridhar global corporate and research and deve- ping India’s talent in data analytics and
Address 144-A, Kalpataru Residency, Opp. Cine Planet, and Chief Executive Offi cer of Bristol lopment operations and are also tap- artifi cial intelligence.
Kamani Marg, Sion (East), Mumbai 400 022. Myers Squibb, Dr. Christopher Boerner,
6. Names and addresses of individuals 1. R. RAGHAVAN and other offi cials. BIOASIA 2024
who own the newspapers or shareholders 144-A, Kalpataru Residency, Opp. Cine Planet,
holding more than one per cent of the total capital Kamani Marg, Sion (East), Mumbai 400 022. “This investment also enables us to 200 delegates visit Genome Valley in Hyderabad
2. VIJAY RAGHAVAN further diversify our global workforce Around 200 delegates comprising – tion centre) and Multitalented Facility
Flat No. 51, 5th Floor, Khushali, Central Avenue Road, by adding world-class local talent and both international delegates and Indian Neovantage (Takshashila) to under-
Chembur, Mumbai 400 071. strengthening our ability to positively companies – were taken in for a guided stand the facility and possible business
I, R.RAGHAVAN, hereby declare that the particulars given above are true to the best of my knowledge and belief. impact patients everywhere,” said tour of the Genome Valley in Hyderabad prospects. As part of the tour, the dele-
Date: 05.03.2024 Signature of Publisher: Dr. Boerner. BMS is among a slew of large in two groups on the inaugural day gates were also shown around facilities
pharma companies setting up their of BioAsia 2024. The groups toured of Bharat Biotech, Biological E Ltd.,
R. RAGHAVAN
innovation hubs in India to service their around IKP Knowledge Park (incuba- and Sai Life Sciences.
136 Chemical Weekly March 5, 2024 Chemical Weekly March 5, 2024 137
Contents Index to Advertisers Index to Products Advertised